The life-sciences company will focus on its core business, including drug development, with restructuring and a divestment ...

A Christmas special with a deep dive into why Generative Ai remains a growing tour de force for both enterprises, consumers, economies and investors. What's in store for 2025?

Fintel reports that on December 11, 2024, RBC Capital downgraded their outlook for CEMEX, S.A.B. de C.V. - Depositary Receipt ...

Kellstrom provides distribution and technical services for the engine aftermarket, supporting OEMs, airlines, lessors and MROs in 75 countries. The company generated roughly $175 million in revenue ...

RBC Capital Markets upgrades Marsh & McLennan stock to Outperform, citing strong growth potential and valuation compared to peers.

Applied Therapeutics Inc (APLT) stock saw a decline, ending the day at $1.21 which represents a decrease of $-0.03 or -2.42% from the prior close of $1.24. The stock opened at $1.22 and touched a low ...

Analysts raise Ollie's price targets, citing strong earnings, unit growth, and market share potential despite challenges.

On Tuesday, Spruce Biosciences Inc (SPRB) stock saw a modest uptick, ending the day at $0.54 which represents no change from the prior close of of $0.54. The stock opened at $0.55 and touched a low of ...

RBC Capital analyst Gregory Renza maintained a Hold rating on Spruce Biosciences (SPRB – Research Report) yesterday and set a price target of ...

In a report released yesterday, Jonathan Atkin from RBC Capital maintained a Buy rating on Equinix (EQIX – Research Report), with a price ...

We recently compiled a list of the 11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now. In this article, we are ...

From M&A and tariffs to new health leaders, here are the top issues for the medtech industry to watch when President-elect ...